Publication | Open Access
Pharmacokinetics, pharmacodynamics and safety of the novel C‐X‐C chemokine receptor 3 antagonist ACT‐777991: Results from the first‐in‐human study in healthy adults
14
Citations
12
References
2023
Year
In this first-in-human study, ACT-777991 showed good tolerability for all doses tested and a PK and TE profile suitable for further clinical development.
| Year | Citations | |
|---|---|---|
Page 1
Page 1